Search Articles
Filter Articles
Found 2,543 articles
CPHI Annual Report predicts AI to transform all processes in drug development by 2026
- 12 Sep 2023
The first part of the influential CPHI Annual Report predicts sizeable progress ahead for AI’s use in pharma, as despite the wider excitement around ChatGPT and other generative AI’s having cooled in recent months, pharma’s real-world applications continue to expand.
12 Ways to Make Your Job Adverts Appeal to Senior Executives
- 11 Sep 2023
In this article, we highlight 12 ways to make your job adverts appeal to senior executives; helping you to bring highly qualified professionals into your workforce to propel your organisation forward.
BC Platforms Appoints Dr. Ben Illigens as Chief Medical Officer
- 8 Sep 2023
BC Platforms (BCP), a global leader in healthcare data management and analytics, today announces the appointment of Dr. Ben M. W. Illigens, an experienced clinician and neuroscientist, as the company’s Chief Medical Officer.
Top Pharma and Life Science Companies in September
- 7 Sep 2023
Here's a list of the top pharma and life science companies hiring in September on PharmiWeb.jobs
Top Recruiters in September
- 7 Sep 2023
Here are the top Pharma and Life Science recruitment organisations advertising in September on PharmiWeb.jobs
-
Alvarez & Marsal appoints a new Managing Director of Healthcare & Life Sciences in Corporate Finance team
- 7 Sep 2023
Global professional services firm Alvarez & Marsal (A&M) has appointed Al-Munther Sultan as a Managing Director of Healthcare & Life Sciences in A&M’s Corporate Finance division.
US Biopharma Financial & IR Strategy Veteran Dr Grace Kim joins MedinCell
- 7 Sep 2023
“We are very proud to welcome Grace, who is recognized as one of the best US investor relations strategists,” said Christophe Douat, CEO of MedinCell. “I’m already seeing the impact of her actions. She has a deep understanding of the US pharma and biotech capital world. I’m convinced that she will leverage this understanding to support our strategy, increase our visibility, build demand, and create long-term value.
Cell and Gene Therapy Industry Pioneer & GMP Expert, Gerhard Bauer, Joins Orgenesis Business, Octomera, to Drive Continued Expansion of POCare Facilities and Service Support
- 7 Sep 2023
Orgenesis, a global biotech company working to unlock the full potential of cell and gene therapies (CGTs), continues to grow the infrastructure of the advanced therapeutic POCare services and facilities supply business, Octomera.
New research alliance with Novo Nordisk to identify therapeutic targets for type 2 diabetes and cardiometabolic diseases
- 7 Sep 2023
The Broad Institute of MIT and Harvard today announced a new research alliance with Novo Nordisk aimed at addressing critical unmet clinical needs in diabetes and cardiometabolic diseases. The collaboration will focus on advancing three programs over the next three years.
NHS 24 Expert in Health Technology Seconded as Professor of Practice at the University of Strathclyde
- 6 Sep 2023
NHS 24 is delighted to announce the appointment of an NHS 24 employee as a Professor of Nursing Practice within the Centre for Future Hospital initiative at the University of Strathclyde.
EvidentIQ Announces Change of Leadership
- 6 Sep 2023
Today, EvidentIQ, a leading provider of end-to-end eClinical and Patient Insights solutions, proudly announces a strategic leadership restructuring, setting the stage for the company's continued growth and commitment to delivering unparalleled results for its clients.
MacroGenics Announces Achievement of $15 Million Milestone Related to Gilead’s Nomination of a Bispecific Research Program
- 6 Sep 2023
MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative antibody-based therapeutics for the treatment of cancer, today announced that its partner, Gilead Sciences, Inc. (NASDAQ: GILD), nominated the first of two research programs, leveraging MacroGenics’ DART® and TRIDENT® platforms for generating bispecific antibodies.
Engitix Announces Appointment of Christopher Stevenson Ph.D., as CSO
- 6 Sep 2023
Engitix Ltd (‘Engitix’), a biotechnology company with a portfolio of drug discovery programmes in fibrosis and solid tumours using its proprietary patient-centric human extracellular matrix (ECM) platform, today announces the appointment of Christopher (Chris) Stevenson, Ph.D. as Chief Scientific Officer (CSO).
Pleco Therapeutics Announces the Appointment of Dr Henno Welgemoed as Chief Medical Officer
- 6 Sep 2023
Pleco Therapeutics BV, a specialty pharmaceutical company developing novel Plecoid™ therapies designed to detoxify the cancer microenvironment today announces the appointment of Dr Henno Welgemoed in the newly created role of Chief Medical Officer (CMO)
8 Reasons to Consider a Career in the Medical Device Sector
- 5 Sep 2023
The medical device sector refers to the industry involved in the design, development, manufacturing and distribution of medical equipment and devices used to diagnose, treat, and monitor health conditions. This broad sector brings together experts from various fields, including engineering, biology, chemistry, medicine, and more.
ACTIMIS post-hoc results on imaging stroke data using Artificial Intelligence reinforces glenzocimab mode of action in stroke patients
- 31 Aug 2023
Acticor Biotech, (ISIN: FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular emergencies, announced today the results of its collaboration with Brainomix Limited, to further explore the imaging data using Artificial Intelligence (AI) from its phase 1b/2a ACTIMIS study.
TherageniX and University of Nottingham Awarded £995K Innovate UK Grant to Develop Powdered Gene Therapy for Bone Regeneration
- 31 Aug 2023
Novel non-viral gene delivery platform to help advance tissue repair following orthopaedic surgery. Funding from Innovate UK’s Transforming Medicines Manufacturing programme supporting innovative technologies for intracellular drug delivery
10 Strategies for Retaining Remote Life Science Talent
- 31 Aug 2023
As the life science industry continues to adapt to the changing work landscape, remote working has become a prevalent practice. While remote work offers flexibility and convenience for employees, it can pose unique challenges for recruiters and hiring managers in the industry.
BioMed X Institute Starts Its First Research Project with Sanofi on Artificial Intelligence for Drug Development
- 31 Aug 2023
BioMed X, a German independent research institute, announces the start of its first research project in collaboration with Sanofi: “Next Generation Virtual Patient Engine for Clinical Translation of Drug Candidates” (VPE).
Barry Simms Named as Elligo Health Research’s Chief Operating Officer
- 30 Aug 2023
Elligo Health Research®, the largest healthcare-enabling research organization, today announced the addition of Barry Simms as Elligo’s Chief Operating Officer (COO). Simms’ expertise in global strategy and partnerships will help further the company’s growth and mission of providing everyone with easy access to participation in research and to accelerate clinical trials along the way.
